Other roundtable participants are:
- Dr Nathalie Strub-Wourgaft, COVID-19 Response & Pandemic Preparedness, Drugs for Neglected Diseases initiative;
- Rob Terry, TDR, the Special Programme for Research and Training in Tropical Diseases
- Naomi Waithira, Mahidol Oxford Research Unit Data Sharing Working Group, COVID-19 Clinical Research Coalition;
- And it will be moderated by, Dr Francois Chappuis, University of Geneva.
The COVID-19 pandemic has increased the importance and the urgency of sharing de-identified individual level clinical and study data. Early signals suggested an unprecedented commitment by the research community to data sharing and transparency.
In practice, however, much more COVID-19 data have been promised than delivered, and many pre-pandemic obstacles to data sharing remain unchanged. The discussion aims to raise awareness of the lack of sharing of de-identified individual level data from COVID-19 clinical studies, share strategies for overcoming some of the obstacles, and identify what is still needed to increase clinical data sharing during the pandemic.
You can catch up with a previous GHF expert panel event featuring IDDO here.
About the Geneva Health Forum
The forum brings together key actors of global health. Created in 2006, it is organized by the Geneva University Hospitals (HUG) and the University of Geneva in partnership with 30 global multisectoral organizations, with the overall goal to contribute to improving health and care access in the world. At the heart of International Geneva, the Geneva Health Forum provides a continuous platform for collaboration and holds one of the largest Global Health conferences every two years. The next GHF conference is taking place from 3 to 5 May 2022, under the theme: “Covid-19 Pandemic and Environmental Emergency: Reinventing Global Health in times of Global Changes”